Why Warren Buffett and other top investors may find troubled UnitedHealth appealing right now

UnitedHealth (UNH) shares surged 10% after high-profile investors, including Warren Buffett's Berkshire Hathaway, David Tepper, and Michael Burry, disclosed new stakes, marking its best day in five years. These significant investments capitalize on UNH's deeply discounted valuation, with the stock down over 50% from its peak and trading at a P/E ratio near 12x, following a series of setbacks including a DOJ investigation, CEO departure, and a major cyberattack. The influx of capital from these prominent figures suggests a belief that the healthcare giant's current challenges are surmountable, offering a compelling long-term value proposition despite its recent controversies.

Analysis

UnitedHealth (UNH) shares experienced a significant 10% rally, their best single-day performance in five years, following the disclosure of new stakes by prominent investors including Berkshire Hathaway, Appaloosa Management, and Michael Burry. This influx of high-profile capital comes after the stock's valuation was cut by more than half from its peak nine months prior, a result of severe headwinds including the suspension of 2025 guidance, a Department of Justice investigation into its billing practices, and a major cyberattack. The investment thesis appears to be centered on a deep value opportunity, with UNH's price-to-earnings ratio trading near a decade-low of 12, compared to its ten-year average of 23. The prevailing view among these investors is likely that the company's current crises are surmountable for a blue-chip industry leader with solid finances and above-average profitability. While analysts acknowledge significant near-term choppiness is probable over the next two years, the involvement of long-term-oriented investors like Berkshire Hathaway suggests a bet on the franchise's ability to recover its prominence and valuation over a three-plus year horizon, a sentiment potentially bolstered by the return of highly-regarded former CEO Stephen Hemsley.

Key Decisions for Investors

• For investors with a long-term horizon of three or more years, the current depressed valuation, now validated by notable deep-value investors, could represent a compelling entry point into a market-leading franchise.
• Traders and investors with shorter time horizons should remain cautious due to expected volatility stemming from the ongoing DOJ investigation, potential fines, and near-term profitability pressures.
• Monitor key developments closely, particularly any resolution or update on the Justice Department probe and the reinstatement of 2025 financial guidance, as these will be critical catalysts for the stock's recovery.
• Consider the healthcare sector's broader underperformance as a potential tailwind, as a reversal in sector sentiment could provide an additional lift to a recovering UNH.